ArticleInternational journal of molecular sciences2026
Circular RNA Expression Profiles in Crimean-Congo Hemorrhagic Fever: Insights into Disease Pathogenesis and Fatal Outcomes.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Crimean-Congo hemorrhagic fever (CCHF) is a severe tick-borne viral disease with high mortality rates and no approved specific antiviral therapy or vaccine. Circular RNAs (circRNAs) are emerging regulators of gene expression and have been implicated in various infectious and inflammatory diseases; however, their role in CCHF remains unknown. In this study, we investigated circRNA expression profiles in peripheral blood samples from CCHF patients and healthy controls. Total RNA was isolated, enriched for circRNAs using RNase R treatment, and analyzed with the Arraystar Human circRNA Array V2 platform. Differential expression analysis was performed using the limma package in R, followed by RT-PCR validation and bioinformatic analyses. Compared with healthy controls, 15 circRNAs were significantly upregulated and 264 were significantly downregulated in CCHF patients. The most highly upregulated circRNAs included hsa_circ_011083, hsa_circ_092556, hsa_circ_001766, hsa_circ_001569, and hsa_circ_027934, whereas hsa_circ_405788, hsa_circ_104982, hsa_circ_002008, hsa_circ_406768, and hsa_circ_037139 were among the most downregulated. Additionally, 641 and 455 differentially expressed circRNAs were identified in fatal-control and fatal-nonfatal comparisons, respectively. Functional enrichment analyses revealed associations with immune response, inflammatory signaling, and host-virus interaction pathways. To our knowledge, this is the first study to characterize circRNA expression patterns in CCHF, providing novel insights into disease pathogenesis and identifying potential biomarkers associated with disease severity and mortality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.